Regents of the University of California’s Sana Biotechnology SANA Stock Holding History

Regents of the University of California’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-156,254	Closed	-$853K	–	7
2024 Q2	$853K	Hold	156,254	–	–	0.47%	5
2024 Q1	$1.56M	Hold	156,254	–	–	0.45%	11
2023 Q4	$638K	Hold	156,254	–	–	0.08%	21
2023 Q3	$605K	Hold	156,254	–	–	0.08%	19
2023 Q2	$931K	Hold	156,254	–	–	0.12%	17
2023 Q1	$511K	Hold	156,254	–	–	0.09%	21
2022 Q4	$617K	Hold	156,254	–	–	0.12%	21
2022 Q3	$938K	Hold	156,254	–	–	0.19%	21
2022 Q2	$1M	Hold	156,254	–	–	0.2%	18
2022 Q1	$1.29M	Sell	156,254 -231,254	-60%	-$1.87M	0.19%	24
2021 Q4	$6M	Hold	387,508	–	–	0.84%	10
2021 Q3	$8.73M	Buy	+387,508	New	+$8.14M	1.03%	10

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Regents of the University of California's SANA Position: Q3 2024 in Review

Regents of the University of California sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 156,254 shares — an estimated $853K sold.

Regents of the University of California first reported a position in SANA in Q3 2021 and held it in 12 quarters. The position peaked at $8.73M in Q3 2021. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

Regents of the University of California reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
Regents of the University of California sold 156,254 Sana Biotechnology shares in Q3 2024, an estimated $853K.
Regents of the University of California first reported a position in Sana Biotechnology in Q3 2021 and held it in 12 quarters.
Regents of the University of California's Sana Biotechnology position peaked at $8.73M in Q3 2021.
155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Regents of the University of California's 13F filing for Q3 2024, filed 12 Nov 2024.